Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary

Nicholas S imon Reed, Eva Gomez-Garcia, Dolores Gallardo-Rincon, Brigitte Barrette, Klaus Baumann, Michael Friedlander, Ganessan Kichenadasse, Jae Weon Kim, Domenica Lorusso, Mansoor R aza Mirza, Isabelle Ray-Coquard

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms most commonly occurring in the gastrointestinal tract or the lungs. More frequent are gastrointestinal tumors, but over the past 30 years, there have been a number of small series or anecdotal case reports on ovarian NETs. Neuroendocrine tumors in the gynecologic tract are uncommon and account for about 2% of all gynecologic malignancies but may also be metastatic from other sites. They require a multimodality therapeutic approach determined by the extent of disease and the primary organ of involvement. Pathological diagnosis is critical to guide therapy. Surgery is the cornerstone of treatment for localized disease. There have been many new developments for treatment of advanced NETs including somatostatin analogs, hepatic artery embolization, chemotherapy, interferons, mammalian target of rapamycin inhibitors and radiolabeled somatostatin analogs. Given the rarity and lack of level I evidence, this is by nature more of a guidance and recommendation for management of these rare tumors until we can mount international studies.

Original languageEnglish (US)
Pages (from-to)S35-S41
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number9
DOIs
StatePublished - Nov 1 2014

Fingerprint

Neuroendocrine Tumors
Carcinoid Tumor
Ovary
Somatostatin
Neoplasms
Hepatic Artery
Sirolimus
Therapeutics
Interferons
Gastrointestinal Tract
Drug Therapy
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reed, N. S. I., Gomez-Garcia, E., Gallardo-Rincon, D., Barrette, B., Baumann, K., Friedlander, M., ... Ray-Coquard, I. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. International Journal of Gynecological Cancer, 24(9), S35-S41. https://doi.org/10.1097/IGC.0000000000000265

Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. / Reed, Nicholas S imon; Gomez-Garcia, Eva; Gallardo-Rincon, Dolores; Barrette, Brigitte; Baumann, Klaus; Friedlander, Michael; Kichenadasse, Ganessan; Kim, Jae Weon; Lorusso, Domenica; Mirza, Mansoor R aza; Ray-Coquard, Isabelle.

In: International Journal of Gynecological Cancer, Vol. 24, No. 9, 01.11.2014, p. S35-S41.

Research output: Contribution to journalArticle

Reed, NSI, Gomez-Garcia, E, Gallardo-Rincon, D, Barrette, B, Baumann, K, Friedlander, M, Kichenadasse, G, Kim, JW, Lorusso, D, Mirza, MRA & Ray-Coquard, I 2014, 'Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary', International Journal of Gynecological Cancer, vol. 24, no. 9, pp. S35-S41. https://doi.org/10.1097/IGC.0000000000000265
Reed NSI, Gomez-Garcia E, Gallardo-Rincon D, Barrette B, Baumann K, Friedlander M et al. Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. International Journal of Gynecological Cancer. 2014 Nov 1;24(9):S35-S41. https://doi.org/10.1097/IGC.0000000000000265
Reed, Nicholas S imon ; Gomez-Garcia, Eva ; Gallardo-Rincon, Dolores ; Barrette, Brigitte ; Baumann, Klaus ; Friedlander, Michael ; Kichenadasse, Ganessan ; Kim, Jae Weon ; Lorusso, Domenica ; Mirza, Mansoor R aza ; Ray-Coquard, Isabelle. / Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary. In: International Journal of Gynecological Cancer. 2014 ; Vol. 24, No. 9. pp. S35-S41.
@article{26e5535b87c94ad9b40935413dbcd9eb,
title = "Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary",
abstract = "Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms most commonly occurring in the gastrointestinal tract or the lungs. More frequent are gastrointestinal tumors, but over the past 30 years, there have been a number of small series or anecdotal case reports on ovarian NETs. Neuroendocrine tumors in the gynecologic tract are uncommon and account for about 2{\%} of all gynecologic malignancies but may also be metastatic from other sites. They require a multimodality therapeutic approach determined by the extent of disease and the primary organ of involvement. Pathological diagnosis is critical to guide therapy. Surgery is the cornerstone of treatment for localized disease. There have been many new developments for treatment of advanced NETs including somatostatin analogs, hepatic artery embolization, chemotherapy, interferons, mammalian target of rapamycin inhibitors and radiolabeled somatostatin analogs. Given the rarity and lack of level I evidence, this is by nature more of a guidance and recommendation for management of these rare tumors until we can mount international studies.",
author = "Reed, {Nicholas S imon} and Eva Gomez-Garcia and Dolores Gallardo-Rincon and Brigitte Barrette and Klaus Baumann and Michael Friedlander and Ganessan Kichenadasse and Kim, {Jae Weon} and Domenica Lorusso and Mirza, {Mansoor R aza} and Isabelle Ray-Coquard",
year = "2014",
month = "11",
day = "1",
doi = "10.1097/IGC.0000000000000265",
language = "English (US)",
volume = "24",
pages = "S35--S41",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "9",

}

TY - JOUR

T1 - Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary

AU - Reed, Nicholas S imon

AU - Gomez-Garcia, Eva

AU - Gallardo-Rincon, Dolores

AU - Barrette, Brigitte

AU - Baumann, Klaus

AU - Friedlander, Michael

AU - Kichenadasse, Ganessan

AU - Kim, Jae Weon

AU - Lorusso, Domenica

AU - Mirza, Mansoor R aza

AU - Ray-Coquard, Isabelle

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms most commonly occurring in the gastrointestinal tract or the lungs. More frequent are gastrointestinal tumors, but over the past 30 years, there have been a number of small series or anecdotal case reports on ovarian NETs. Neuroendocrine tumors in the gynecologic tract are uncommon and account for about 2% of all gynecologic malignancies but may also be metastatic from other sites. They require a multimodality therapeutic approach determined by the extent of disease and the primary organ of involvement. Pathological diagnosis is critical to guide therapy. Surgery is the cornerstone of treatment for localized disease. There have been many new developments for treatment of advanced NETs including somatostatin analogs, hepatic artery embolization, chemotherapy, interferons, mammalian target of rapamycin inhibitors and radiolabeled somatostatin analogs. Given the rarity and lack of level I evidence, this is by nature more of a guidance and recommendation for management of these rare tumors until we can mount international studies.

AB - Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms most commonly occurring in the gastrointestinal tract or the lungs. More frequent are gastrointestinal tumors, but over the past 30 years, there have been a number of small series or anecdotal case reports on ovarian NETs. Neuroendocrine tumors in the gynecologic tract are uncommon and account for about 2% of all gynecologic malignancies but may also be metastatic from other sites. They require a multimodality therapeutic approach determined by the extent of disease and the primary organ of involvement. Pathological diagnosis is critical to guide therapy. Surgery is the cornerstone of treatment for localized disease. There have been many new developments for treatment of advanced NETs including somatostatin analogs, hepatic artery embolization, chemotherapy, interferons, mammalian target of rapamycin inhibitors and radiolabeled somatostatin analogs. Given the rarity and lack of level I evidence, this is by nature more of a guidance and recommendation for management of these rare tumors until we can mount international studies.

UR - http://www.scopus.com/inward/record.url?scp=84936126676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936126676&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000265

DO - 10.1097/IGC.0000000000000265

M3 - Article

C2 - 25341578

AN - SCOPUS:84936126676

VL - 24

SP - S35-S41

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 9

ER -